Trevi Therapeutics (TRVI) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.07% |
| Dec 31, 2025 | -3.45% |
| Sep 30, 2025 | -4.39% |
| Jun 30, 2025 | 99.58% |
| Mar 31, 2025 | -0.19% |
| Dec 31, 2024 | 68.98% |
| Sep 30, 2024 | -10.89% |
| Jun 30, 2024 | -8.52% |
| Mar 31, 2024 | -12.37% |
| Dec 31, 2023 | -7.88% |
| Sep 30, 2023 | -5.75% |
| Jun 30, 2023 | -6.55% |
| Mar 31, 2023 | -5.33% |
| Dec 31, 2022 | -2.22% |
| Sep 30, 2022 | 81.61% |
| Jun 30, 2022 | 478.37% |
| Mar 31, 2022 | -38.72% |
| Dec 31, 2021 | 50.04% |
| Sep 30, 2021 | -35.84% |
| Jun 30, 2021 | -25.12% |
| Mar 31, 2021 | -13.18% |
| Dec 31, 2020 | -23.40% |
| Sep 30, 2020 | -11.04% |
| Jun 30, 2020 | -14.45% |
| Mar 31, 2020 | -14.20% |
| Dec 31, 2019 | -10.15% |
| Sep 30, 2019 | -10.33% |
| Jun 30, 2019 | 158.63% |
| Mar 31, 2019 | -5.46% |
| Dec 31, 2018 | -7.00% |
| Sep 30, 2018 | -7.33% |
| Jun 30, 2018 | -6.57% |